Synergy of Drugs and Devices for Treating PAD: A Concerted Approach to Improve Patient Outcomes
Wednesday, April 14, 2021
9 pm ET/ 8 pm CT
|
|
|
Moderator and Faculty
-
Moderator: Teresa Carman, MD, University Hospitals of Cleveland
-
Elissa Altin, MD, Yale New Haven Health
-
Herbert Aronow, MD, MPH, Lifespan
-
Manesh Patel, MD, Duke University School of Medicine
|
|
Panelists
-
Subhash Banerjee, MD, University of Texas Southwestern Medical Center
-
Mehdi H. Shishehbor, DO, MPH, PhD, University Hospitals of Cleveland
|
|
What will the live webcast address?
- Defining Clinical Risk Predictors of Endovascular PAD Patients
- Does Lower Extremity Revascularization Strategy Influence my Antithrombotic Regimen?
- Antithrombotic Therapy in CAD/PAD patients: My take-homes on Contemporary Evidence
|
|
Educational Grants provided by:
Boston Scientific
Medtronic
Philips
|
|
This activity has been approved for AMA PRA Category 1 Credit™.
|
|
Subhash Banerjee,
MD, FACC, FSCAI
University of Texas Southwestern Medical Center
|
|
Emmanouil S. Brilakis,
MD, PhD, FACC, FAHA,
FSCAI, FESC
Minneapolis Heart Institute at Abbott Northwestern Hospital
|
|
Mehdi H. Shishehbor,
DO, MPH, PhD, FACC,
FAHA, FSCAI
University Hospitals of Cleveland
|
|
Paul Sorajja, MD, FACC,
FAHA, FSCAI
Minneapolis Heart Institute at Abbott Northwestern Hospital
|
|
|
|
|
|
|
|
